Israel’s AISAP (see here previously) has received US FDA approval for its CARDIO point-of-care ultrasound (POCUS) platform. It allows accurate diagnosis of up to 90% of the most common cardiac parameters within minutes, either in an incident or during treatment.
https://nocamels.com/2024/08/startup-gets-fda-approval-for-cardiac-ultrasound-software/
https://streetlight.s3.eu-north-1.amazonaws.com/Review-screen.mp4